CD19 and autoimmune disease: ,24,31 A plausible explanation for the difference in kinetics is that the CABA-201 infusion product is frozen post-manufacture and is thawed immediately before infusion, whereas published literature with other CD19 4-1BBζ CAR T infusion products given to autoimmune disease patients have been infused fresh without a freeze/thaw step post-manufacture.12